Palvella Therapeutics Inc (PVLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,767 | -41,715 | -29,001 | -17,656 | -8,185 |
| Accounts receivable | N/A | 387 | 358 | 358 | N/A |
| Accounts payable and accrued liabilities | 851 | 1,260 | 104 | 1,240 | 1,124 |
| Other Working Capital | -406 | 3,816 | 12 | 165 | -967 |
| Other Operating Activity | 4,458 | 11,246 | 8,447 | 3,691 | 1,260 |
| Operating Cash Flow | $-10,864 | $-25,006 | $-20,080 | $-12,202 | $-6,768 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | -55,440 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-55,440 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 230,956 | 763 | 658 | 416 | 67 |
| Other Financing Activity | -16,225 | -1,423 | -1,269 | -1,269 | -1,269 |
| Financing Cash Flow | $214,731 | $-660 | $-611 | $-853 | $-1,202 |
| Exchange Rate Effect | -15 | 46 | 656 | -114 | -6 |
| Beginning Cash Position | 57,982 | 83,602 | 83,602 | 83,602 | 83,602 |
| End Cash Position | 206,394 | 57,982 | 63,567 | 70,433 | 75,626 |
| Net Cash Flow | $148,412 | $-25,620 | $-20,035 | $-13,169 | $-7,976 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,864 | -25,006 | -20,080 | -12,202 | -6,768 |
| Free Cash Flow | -10,864 | -25,006 | -20,080 | -12,202 | -6,768 |